Phase II AK Study in Organ Transplant Patients

Clinical trial NCT00829192 · UNKNOWN

Trial details

NCT number: NCT00829192
Sponsor: Clinuvel Pharmaceuticals Limited
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Actinic Keratoses Carcinoma, Squamous Cell Organ Transplant Recipients

Start date: 2007-11-01
Primary completion: 2012-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.